THYROID CANCER Successful remnant ablation-what is success?

Thera P. Links; Anouk N. A. van der Horst-Schrivers

doi:10.1038/nrendo.2012.113

THYROID CANCER Successful remnant ablation-what is success?

Thera P. Links^*, Anouk N. A. van der Horst-Schrivers

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

8 Citations (Scopus)

Abstract

Radioactive iodine ablation therapy is a standard treatment for most patients with differentiated thyroid cancer to prevent relapse. The effective dose of radioactive iodine and optimal preparation has been investigated in two recent studies but these factors still need to be confirmed.

Original language	English
Pages (from-to)	514-515
Number of pages	2
Journal	Nature reviews endocrinology
Volume	8
Issue number	9
DOIs	https://doi.org/10.1038/nrendo.2012.113
Publication status	Published - Sep-2012

Keywords

RADIOIODINE
I-131

Access to Document

10.1038/nrendo.2012.113

Embargoed Document

Thyroid cancer: Successful remnant ablation—what is success?
Final publisher's version, 156 KB

Cite this

@article{20294b9abcb84c349ad56ba6724bdc1e,

title = "THYROID CANCER Successful remnant ablation-what is success?",

abstract = "Radioactive iodine ablation therapy is a standard treatment for most patients with differentiated thyroid cancer to prevent relapse. The effective dose of radioactive iodine and optimal preparation has been investigated in two recent studies but these factors still need to be confirmed.",

keywords = "RADIOIODINE, I-131",

author = "Links, {Thera P.} and {van der Horst-Schrivers}, {Anouk N. A.}",

year = "2012",

month = sep,

doi = "10.1038/nrendo.2012.113",

language = "English",

volume = "8",

pages = "514--515",

journal = "Nature reviews endocrinology",

issn = "1759-5029",